Keywords: study, questions, safety, pfizer, bextra, there, been

Study questions safety of Pfizer's Bextra

Article | 15 November 2004

Print This

There have been further concerns raised over the safety of the COX-2 inhibitor class at the American Heart Association meeting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in